Hahn Mark W's Form 4 filing
Verona Pharma plc (VRNA) · filed Oct 22, 2024
- Accession no.
- 0001104659-24-110658
- Filed
- Oct 22, 2024
- Trade date
- Oct 18-22, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $2.30M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hahn Mark WCIK 0001408502 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 18, 2024 | Ordinary Shares | SSaleDisposed | −249,728 | $4.38 | −$1,093,808.64 | 14,089,960 | Direct | |
| Oct 21, 2024 | Ordinary Shares | SSaleDisposed | −116,696 | $4.38 | −$511,128.48 | 13,973,264 | Direct | |
| Oct 22, 2024 | Ordinary Shares | SSaleDisposed | −159,344 | $4.38 | −$697,926.72 | 13,813,920 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.